These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23693064)

  • 21. Genetically modified cells, or how some cancers occur.
    Bentley P
    Nurs Times; 1999 Nov 3-9; 95(44):48-9. PubMed ID: 10983082
    [No Abstract]   [Full Text] [Related]  

  • 22. High penetrance of sequencing errors and interpretative shortcomings in mtDNA sequence analysis of LHON patients.
    Bandelt HJ; Yao YG; Salas A; Kivisild T; Bravi CM
    Biochem Biophys Res Commun; 2007 Jan; 352(2):283-91. PubMed ID: 17123466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer predisposition genetic testing and risk assessment counseling. Oncology Nursing Society.
    Oncol Nurs Forum; 2000 Oct; 27(9):1349. PubMed ID: 11221804
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular genetic diagnosis of familial tumors.
    Tomita N; Oto M
    Int J Clin Oncol; 2004 Aug; 9(4):246-56. PubMed ID: 15375700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we really afford to spend NHS cash on genetic testing for cancer?
    Nurs Times; 2002 Oct 8-14; 98(41):3. PubMed ID: 12430394
    [No Abstract]   [Full Text] [Related]  

  • 26. Code you.
    Mettner J
    Minn Med; 2007 May; 90(5):26-9, 40. PubMed ID: 17550082
    [No Abstract]   [Full Text] [Related]  

  • 27. DNA diagnosis and the emergence of cancer genetic services in European health care.
    Stemerding D; Koch L; Bourret P
    Eur J Hum Genet; 1997; 5 Suppl 2():25-30. PubMed ID: 9450191
    [No Abstract]   [Full Text] [Related]  

  • 28. Likelihood of undergoing genetic testing for cancer risk: a population-based study.
    Bosompra K; Flynn BS; Ashikaga T; Rairikar CJ; Worden JK; Solomon LJ
    Prev Med; 2000 Feb; 30(2):155-66. PubMed ID: 10656843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical aspects of delivering hereditary cancer risk counseling.
    DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
    Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personal genome sequencing: the answer to all of our worries.
    Nelkin D
    Hastings Cent Rep; 2003; 33(1):9. PubMed ID: 12613377
    [No Abstract]   [Full Text] [Related]  

  • 31. Disparities in genetic testing: thinking outside the BRCA box.
    Hall MJ; Olopade OI
    J Clin Oncol; 2006 May; 24(14):2197-203. PubMed ID: 16682739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer genetics.
    Goff S; Jacobs C; Robinson L; Webb P
    Eur J Cancer Care (Engl); 2010 Jul; 19(4):424. PubMed ID: 20642625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic consultation: hereditary cancer risk?].
    de Pauw A; Stoppa-Lyonnet D
    Rev Prat; 2011 Apr; 61(4):538-41. PubMed ID: 21548240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer genetic testing and assisted reproduction.
    Offit K; Kohut K; Clagett B; Wadsworth EA; Lafaro KJ; Cummings S; White M; Sagi M; Bernstein D; Davis JG
    J Clin Oncol; 2006 Oct; 24(29):4775-82. PubMed ID: 16840542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk.
    Wakefield CE; Homewood J; Mahmut M; Taylor A; Meiser B
    Patient Educ Couns; 2007 Dec; 69(1-3):29-38. PubMed ID: 17706910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene testing for cancer susceptibility.
    Reiser G; Schaefer GB
    Nebr Med J; 1996 Dec; 81(12):416-8. PubMed ID: 9046792
    [No Abstract]   [Full Text] [Related]  

  • 39. Catalogue, cause, complexity and cure; the many uses of cancer genome sequence.
    Wooster R; Bachman KE
    Curr Opin Genet Dev; 2010 Jun; 20(3):336-41. PubMed ID: 20382522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.